Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zepatier in HCV G1b Cirrhosis (GECOM)
NCT02732405Phase 3Unknown
- Sponsor
- Humanitas Research Hospital
- Start
- May 2016
- Primary completion
- Dec 2016
- Modality
- Small Molecules
01
Overview
Phase 3, open-label, single-arm trial of grazoprevir in hepatitis C virus infection, sponsored by Humanitas Research Hospital. Primary endpoint: Sustained Virologic Response 12 weeks after discontinuation. Status: unknown.
02
Drugs
grazoprevir
03
Conditions
hepatitis C virus infection
Beyond the preview
Go deeper on NCT02732405.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02732405.